Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	22.48	29.91	24.42
Graham Fair Price	-20.33	4.92	6.18
PEG	434.99	-0.53	0.10
Price/Book	-5.34	2.10	2.22
Price/Cash Flow	1054.07	-114.54	9.92
Prices/Earnings	58.52	19.77	12.47
Price/Sales	29.19	5.74	4.45
Price/FCF	1054.07	-114.54	9.92
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-4.35	0.40	0.42
Operating Margin	2.25	0.29	0.29
ROA	-41.62	< 0.005	< 0.005
ROE	0.04	0.03	-40.28
ROIC	0.03	0.01	-45.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	0.01	275.22
Dividends QOQ	310.04	-1.00	-99.68
EBIT QOQ	0.20	-0.23	16.09
EPS QOQ	1.25	-0.37	-70.37
FCF QOQ	4.46	-1.08	-75.68
Revenue QOQ	0.40	-0.24	-39.45
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	12.99	15.19	16.97
Days Sales Outstanding (DSO)	40.42	64.30	59.09
Inventory Turnover	6.93	5.93	-14.51
Debt/Capitalization	0.71	0.71	0.50
Quick Ratio	1.18	1.35	15.13
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.18	6.37	3.10
Cash	3.56	3.99	12.24
Capex	-0.87	-0.55	37.02
Free Cash Flow	1.38	-0.12	-91.54
Revenue	3.08	2.33	-24.46
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.30	1.47	13.35
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.87	14.76	24.37
Naive Interpretation	Member

06 - Financial Health · Weak

Rating